Canada

Teva's commitment to biosimilars

Teva's commitment to biosimilars 1026X430.jpg

Teva Canada exists for one simple reason: to help people feel better and live better lives.

At Teva Canada we understand that the Canadian healthcare market is changing. We want to be an active partner of this change. That’s why we are focusing our research and development efforts on innovative biologics and biosimilars while remaining dedicated to providing products that both consumers and healthcare providers can trust.

Our well-established and trusted history in making and supplying medications can be seen in our strong product line of 1,800 medicines.

We are committed to building on this history through the investment and development of biosimilars that are comparable in safety, purity and potency.

 

Safety

 

Purity

 

Potency

 
icon_safety.png   icon_purity.png   icon_potency.png  

 

A woman in a lab coat holds a magnifying glass, illustrating her focus on the research and understanding of biosimilars.

Understanding biosimilars

Dive deeper into the facts about Biosimilar.

Read more
A woman in a white lab coat examines a cabinet, symbolizing research on biosimilars in the Canadian market.

Biosimilars in the Canadian market

Take a look at the Biosimilar Regulatory pathway.

Read more